Streetwise Reports' Article Archives — Current Month (81)
Mining Company Updates PEA for Ontario Project (10/20/2019)
This is a step forward as the firm continues to advance and derisk the project.
Q4 Guesstimates: Precious Metals, Miners and Stocks (10/20/2019)
Sector expert Michael Ballanger reflects on modern monetary policy and discusses his most recent investment decisions.
The production numbers are reviewed in a BMO Capital Markets report.
John Newell of Fieldhouse Capital Management explores the investment opportunities presented by this project generator in a district rich with historic mine strikes.
Dermira shares traded higher today after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference.
Seplat Petroleum to Acquire Eland Oil & Gas (10/17/2019)
A glance at the deal is provided in a Pareto Securities report.
Shares of Protalix Biotherapeutics skyrocketed today on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease.
This marks the product developer's entry into a new segment of the public venues market.
The company expects action by President Trump following the nuclear fuel working group's recommendations.
The transaction details are relayed in a CIBC report.
Drilling is about to start at one of the company's projects and continues at the other two.
Accordingly, the company continues an expanded, aggressive stepout drill program there.
Healthcare Tech Firm Signs Five New Clients in Texas (10/16/2019)
The company just landed another five clients in Texas and now plans to build out sales teams in five additional states.
Pan Orient Energy: The New Orient Express (10/16/2019)
Veteran investor and newsletter writer Chen Lin explains the upside he sees with this energy company.
Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specific clinical trial and regulatory milestones are met.
It did this through capital improvements at each of its various facilities.
The purchase expands the holdings of its principal project there.
Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close.
Skyharbour Drilling Deeper in Athabasca Basin (10/16/2019)
Jordan Trimble, CEO of Skyharbour Resources, sits down with Maurice Jackson of Proven and Probable to discuss his company's exploration plans in Canada's uranium-rich Athabasca Basin.
Platinum Group Metal Cowboys in Montana (10/15/2019)
A small-cap company in Montana is exploring to find out if its property contains "Platreef-style" PGE mineralization.
The goal is to reduce the time healthcare workers spend on mundane tasks and thereby improve patient care.
Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility.
The company will use these new data in designing the mine and optimizing the prefeasibility study.
Q3/19 production totals from the company's various assets are discussed in a CIBC report.
Technical analyst Clive Maund outlines the reasons this stock might break higher.
Prominent Gold Stock at 'Buy Spot' (10/14/2019)
Technical analyst Clive Maund's charts explain why he sees this stock as a buy.
Maurice Jackson of Proven and Probable discusses the latest developments in the Goodpaster District with this company's chief executive and senior geologist.
Shares of Cerecor Inc. are trading higher today after reporting that it will sell its pediatric portfolio to Aytu BioScience for $32 million in a combination cash and stock deal.
Also, a geochemical survey identifies four new exploration targets.
Explorer a 'Highly Attractive Speculative Play' (10/12/2019)
This miner has taken a hit, but technical analyst Clive Maund explains why the stock may be a good buy at current levels.
Technical analyst Clive Maund believes this stock could gain traction soon.
These results are from one of the company's high-priority regional prospects.
Recent assays demonstrate high prospectivity between two existing zones.
Energy Stock Is 'Looking to Break Out of Large Base' (10/11/2019)
Technical analyst Clive Maund explains why he believes this company with projects in Thailand and Indonesia is about ready to start another upleg.
Junior Gold Stock 'On the Up' (10/11/2019)
Technical analyst Clive Maund charts a junior explorer and explains why he sees it as a speculative buy.
Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie.
Sector expert Michael Ballanger's take on this week's news from the financial markets informs his most recent investment decisions.
Shares of Ra Pharmaceuticals doubled today after the firm announced that it will be acquired by Belgian firm UCB for $48 per share in an all cash deal.
The changes made and the reasons for them are detailed in a Raymond James report.
Through continued drilling, the Canadian company is pursuing further extensions.
The pros and cons of the deal are discussed in an iA Securities report.
The details regarding those metals sales are provided in a BMO Capital Markets report.
The partnership could put both companies at the forefront of the emerging 3D-AR market.
The developer received an initial order from Taiwan for the product.
Thailand Exploration Well Hits Net Oil Pay (10/09/2019)
The well will be production tested after the required permit is obtained.
Soliton Inc. shares traded 10% higher today after advising that later this month it will present the data from clinical trials for its Rapid Acoustic Pulse device used in the treatment of keloid and hypertrophic scars at the American Society for Dermatologic Surgery Annual Meeting.
Chris Taylor, CEO of Great Bear Resources, speaks to Maurice Jackson of Proven and Probable about what the drills are turning up at the Dixie Gold Project in Ontario's Red Lake District.
Brazil Mine 'Demonstrates Growth is Real' (10/08/2019)
Conclusions from a recent site visit are delivered in a CIBC report.
Data from this study should be released by the end of this year.
The key reasons this story is compelling are given in an H.C. Wainwright & Co. report.
Progress has been made in all areas, from testing the product to evaluating distributors.
Shares of Nordic American Tankers are trading 16.5% higher today setting a 52-week intraday high stock price as the company reported great demand for its Suezmax oil tankers.
The company reported its FY19 revenue and profit and FY20 financial goal.
Management presented its recent, major corporate developments and product changes.
This is another addition to the Vancouver-based company's growing asset portfolio.
These increases indicate an "attractive, near-term development opportunity," the company states.
This will help its customers access the products and tools they need more sustainably.
The Critical Investor digs into what the proposed joint venture means for this junior project generator.
Akcea Therapeutics' shares are trading 30% higher today on news that it has entered into a worldwide exclusive licensing agreement with Pfizer for AKCEA-ANGPTL3-LRx used in the treatment of patients with cardiovascular and metabolic diseases.
Analyst: Gold Explorer Warrants Top Pick Status (10/07/2019)
The rationale for this view of the company is provided in an Echelon Wealth Partners report.
Free Market Capitalism: Laughably Predictable (10/05/2019)
Sector expert Michael Ballanger offers his observations on recent market fluctuations.
The Canadian company will look to its new board head for strategic leadership.
Now, the company is completing a helicopter-supported field program there.
Healthcare Tech Firm Expands Patient Base in Texas (10/04/2019)
The company landed five new U.S. facilities as customers.
Shares of RingCentral and Avaya Holdings are soaring today after the announcement that RingCentral will become Avaya's exclusive Unified Communications as a Service (UCaaS) solutions provider.
The deal and the assets are described in a ROTH Capital Partners report.
The drill results are relayed and interpreted in a Haywood report.
In a research report, Raymond James revisits and revises its Q3/19 projections on this company.
This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection.
After years of work, this milestone is a significant one for the process and the company's development.
The goals are to test for a greater depth of the current resource and for high-grade feeder structures.
One area of mineralization encountered could represent a third discovery zone.
This is the eighth public facility to partner with the product's developer in this way.
Non-invasive medical device maker Zynex Inc's. shares are trading 12% higher on an overall down market day after the company reported that Q3/19 orders are up 95% over the same period in 2018.
Teekay Offshore Partners shares are trading more than 30% higher today on news that Brookfield Business Partners will be purchasing all un-owned common units of the firm for $1.55 per share.
The multiplatform technology to be provided will allow for mobile, virtual product demonstrations.
Agreement Reached on Royalty on Quebec Project (10/01/2019)
The asset's operator and its royalty holder have reached agreement and clarified the terms of the royalty.
A new collaboration will ensure compliance with wireless, electromagnetic compatibility and safety standards.
This is because the trio shares similar and correlatable geology and/or mineralization styles.
Maple Gold for $3.02 an Ounce US (10/01/2019)
Bob Moriarty of 321 Gold explains why he has been buying shares of this gold explorer with a project in Quebec.
Deflation or Inflation: Gold Doesn't Care (10/01/2019)
Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss recession, central bank panic and an outrageous gold price.
|"The aerial survey over SYH's Moore identified several drill targets."|
|"MAG's latest dip back into support provides a favorable entry point."|
|"LIO is starting its most important, cost effective drill program."|
|"The Metro Toronto Convention Centre will beta test SCAN's HEXWAVE."|
|"We believe SEA could make a significant discovery on Snowstorm."|